We would love to hear your thoughts about our site and services, please take our survey here.
JPMorgan raises TP ICAP price target to 274 (259) pence - 'overweight'
Christopher Mills from Harwood Capital talks about TCAP at 54:20
https://www.youtube.com/watch?v=M_iIre1pAW4&t=3260s
JPMorgan raises TP ICAP price target to 259 (253) pence - 'overweight'
Nice rise this week. Plenty of gas left in the tank.
Good to see another director buy albeit only 25k shares. Insider buying has sadly been absent for a long time and been an ongoing criticism leveled against the Board. Glad they're listening now.
Silly drop. Just added. Absolute steal under 160p!!
A couple of delayed buys reported after the bell with a combined volume of over 2 million. Definitely haven't seen that for a while. Hopefully the tide is turning.
Well, I guess I've found the answer to my previous question. It's so disappointing to see the share price sub 160 again. To be honest, I didn't think the trading update was too bad apart from Liquidnet. Obviously, the market feels otherwise. Wish a PE fund would stump up the cash and put TCAP out of its prolonged share misery. Such an unbelievable bargain at these levels.
Any views as to where the share price is heading? The recent price weakness doesn't look encouraging.
JPMorgan raises TP ICAP price target to 235 (210) pence - 'overweight'
Peel Hunt also reiterated their Buy recommendation with a 240p price target.
Agree Liquidnet was a little disappointing, but rest of the results were very solid. Nothing in there to justify such a big drop, which makes me conclude it's mainly sentiment from SVB. I think we'll be blue by the end of the day, once sense prevails.
Don't think the drop is specific to the results. All Financials are being hit hard again today following the SVB fallout. This is going to require some patience.
Tree shake ahead of results next week. Barely any sellers. Tells you everything you need to know.
Chunky buying again today. Looking good.
Looks like some serious stakebuilding going on this morning.
Personally, I don't think the management team have done themselves any favours in remaining silent. I would have expected an RNS this morning, simply acknowledging the media reports about failed negotiations regarding the sale of the data division, but reassuring investors they have a clear strategy to realise shareholder value. By remaining silent, they look weak and removed from investors concerns. I wouldn't be surprised if the share price drifts until the Finals. They better be good, otherwise Phase 2 and other institutional investors will be sharpening their knives!!
Totally agree. I'd imagine there must be a pretty good degree of confidence in current trading to justify the decision not to sell the data division. Looking forward to Final results on 14th March.
Seems like an odd decision not to sell Parameta and release shareholder value. Perhaps management have other plans for the business which they're not able to disclose yet. I would have expected much stronger weakness in the share price if investors were genuinely disappointed by the decision. This could be a good opportunity to top up? Personally, I'm fully loaded. My biggest share holding by quite a large margin!
Unusual share price weakness today, despite market strength. Does anyone know whether there is any news? Thanks.
Seems to have a hard time staying above 180p for any meaningful time. Always seems to be a sell-off early afternoon. I can understand why you're trading it.